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A liquid chromatographie (LC) method was developed earlier for the determination of the 
enantiomeric purity of timolol maleate, a p-adrenergic blocker, used in therapeutics as a 
single enantiomer (S-timolol), and was recently introduced in the European 
Pharmacopoeia [1]. 
This method was based on the use of a column packed with a chiral stationary phase, 
cellulose tris-3,5-dimethylphenylcarbamate (5J.1m), in the normal phase mode, with a 
mixture ofhexane, 2-propanol and diethylamine as mobile phase. The flow rate was set at 
1.0 ml/min and UV detection was performed at 297 nm. 

The objective of this study was to adapt this LC method in order to make it suitable also 

for the determination ofother closely related impurities. 

The concentration of the organic modifier, (2-propanol) and of the competing amine 





An adequate resolution of the critical pair (R-timolol/isotimolol) was obtained using a 

mobile phase containing n-hexane, 2-propanol and diethylamine in the proportions: 

96/4/0.2 (v/v/v) and a column temperature of 200 C. Under these conditions, the 

resolution between the two enantiomers of timolol was still very high (about 4) and the 

latter were also weil separated from the other potential impurities. 

The developed method was validated. Very good results with respect to relationship 

between response and concentration (linearity), accuracy and precision were obtained. 

The limits of quantification for R-timolol and the other impurities were lower than 0.1 %. 
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